Evidence map›Paper›PMID 18815866›Full record

ArticleClinical and experimental medicine2008

Rapid genotyping of tumor necrosis factor alpha with fluorogenic hybridization probes on the LightCycler.

Naoko Hayashi, Yu Imamura, Yukiharu Hiyoshi, Hiroshi Takamori, Toru Beppu, Masahiko Hirota, Hideo Baba

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical and experimental medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Naoko HayashiDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
Yu Imamura
Yukiharu Hiyoshi
Hiroshi Takamori
Toru Beppu
Masahiko Hirota
Hideo Baba
Kumamoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genotyping of tumor necrosis factor alpha (TNF-alpha) has become an important procedure in the selection of high-risk population of septic shock and prevention from death due to septic shock. We present a single-tube method for TNF-alpha genotyping that performed on the LightCycler by melting curve analysis with allele-specific fluorescent probe. A fragment covering the polymorphic site is amplified in the presence of two fluorescently labeled hybridization probes. During amplification, probe hybridization is observed as fluorescence increases every cycle as the product accumulates during amplification. A single base mismatch resulted in a melting temperature (Tm) shift of 7-8 degrees C, allowing for the easy distinction of a common type allele from the polymorphic allele. Using this method, genotyping of 104 samples was completed within 1 h without the need for any post-PCR sample manipulation, thereby eliminating the risks of end-product contamination and sample tracking errors. The genotypes determined with the LightCycler were identical when compared with a conventional sequencing. The simplicity, speed, and accuracy of real-time PCR analysis using FRET probes make it the method of choice in the clinical laboratory for genotyping of a variety of human DNA polymorphisms and mutations.

Indexed as

Base SequenceDNA PrimersDNA ProbesFluorescence Resonance Energy TransferGenetic Predisposition to DiseaseGenotypeHumansIn Situ Hybridization, FluorescencePolymerase Chain ReactionPolymorphism, GeneticSepsisTumor Necrosis Factor-alphaDNA PrimersDNA ProbesTumor Necrosis Factor-alpha

Identifiers

PMID18815866
OpenAlexW2002729910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.